Trump signs order raising Canada tariffs to 35% from 25%
Lake Charles D II, Chairman and Representative Director of Aflac Incorporated (NYSE:AFL), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Lake sold a total of 52,972 shares of Aflac common stock over two days, with transactions taking place on March 7 and March 10, 2025. The insurance giant, currently valued at $58.19 billion, maintains a strong financial health score according to InvestingPro analysis.
The sales were executed at prices ranging from $106.61 to $108.40 per share, bringing the total value of the transactions to approximately $5.69 million. Following these transactions, Lake holds 49,962 shares in direct ownership and 1,299 shares in a 401(k) plan. The stock currently trades at a P/E ratio of 11.03, with analyst targets ranging from $93 to $122 per share.
The transactions were conducted under a Rule 10b5-1 trading plan, a pre-established plan allowing company insiders to sell stocks at predetermined times, providing a measure of protection against accusations of insider trading. Notably, Aflac has maintained 41 consecutive years of dividend increases, demonstrating strong financial stability. Discover more comprehensive insights and analysis with InvestingPro’s detailed research report.
In other recent news, AFLAC Incorporated reported its fourth-quarter earnings for 2024, revealing a notable earnings per share (EPS) shortfall. The EPS came in at $1.56, falling below the forecasted $1.62, despite strong revenue performance that exceeded expectations with $5.4 billion reported against an anticipated $4.23 billion. Barclays (LON:BARC) responded to these results by lowering its price target on AFLAC to $95.00 from $98.00, maintaining an Underweight rating due to the earnings miss and concerns over the company’s short-term prospects in Japan. Conversely, CFRA increased its price target for AFLAC to $112.00, maintaining a Buy rating, citing a valuation of AFLAC shares at 15.1 times CFRA’s 2026 EPS estimate.
Piper Sandler maintained an Overweight rating on AFLAC, emphasizing the company’s lower risk profile due to less exposure to variable interest entities compared to peers. The firm also highlighted AFLAC’s upcoming cancer insurance product launch in Japan as a potential positive catalyst. Despite the challenges, AFLAC’s investment income showed an 18% increase, helping to offset lower premiums, and the company reported an adjusted EPS growth of 24.8% for the quarter. The insurer’s board declared a first-quarter dividend of $0.58 per share, reaffirming its commitment to shareholder returns through dividends and share repurchases.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.